Package 69367-138-05

{"route": ["ORAL"], "spl_id": "12e91d37-d793-4a08-9455-fefe6eb0d2c7", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0369367137010", "0369367138017"], "unii": ["X4HES1O11F"], "rxcui": ["197311", "197313"], "spl_set_id": ["f352a641-988e-4878-8016-2b69cd6ee548"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (69367-138-01)", "package_ndc": "69367-138-01", "marketing_start_date": "20230620"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69367-138-05)", "package_ndc": "69367-138-05", "marketing_start_date": "20230620"}], "brand_name": "Acyclovir", "product_id": "69367-138_12e91d37-d793-4a08-9455-fefe6eb0d2c7", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "69367-138", "generic_name": "Acyclovir", "labeler_name": "Westminster Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "800 mg/1"}], "application_number": "ANDA210401", "marketing_category": "ANDA", "marketing_start_date": "20230620", "listing_expiration_date": "20261231"}